Advog M 0.3mg Tablet (Metformin 500 mg/Voglibose 0.3 mg)

Metformin and Voglibose are the two active components of the combination drug Advog M 0.3mg Tablet. For the management of type 2 diabetes mellitus, it is frequently recommended. Voglibose is an alpha-glucosidase inhibitor, while Metformin belongs to the biguanide class of drugs. Through a variety of methods of action, the combo drug aids in blood sugar regulation.

How Does Advog M Work?

Advog M 0.3 Tablet manages type 2 diabetes using two main mechanisms:

1. Metformin: Metformin increases the sensitivity of tissues to insulin and lowers the amount of glucose produced by the liver. It also aids in reducing the intestinal absorption of glucose. Metformin aids in lowering blood sugar levels by focusing on these pathways.
2. Voglibose: Voglibose prevents digestive enzymes from dissolving complex carbohydrates into simple sugars. Voglibose aids in lowering blood sugar increases after meals by slowing down the digestion and absorption of carbs.

How to Take Advog M 0.3 Tablet

1. Advog M 0.3 Tablet should be taken exactly as directed by your doctor. Without first consulting your doctor, never take more medication than is advised or alter the dosage.
2. Advog M is often taken orally with or just prior to meals. This enhances the effectiveness of the method for regulating blood sugar.
3. With a glass of water, swallow the tablet whole. The tablet should not be broken, chewed, or crushed because it releases the medication gradually over time.
4. Adherence: To maintain consistent blood sugar control, take Advog M regularly at the same time(s) every day. To help you remember to take your prescription, set reminders or create a routine.

Related Product

Advog 0.2mg Tablet
Advog M 0.2 Tablet
Advog M 0.3 Tablet

Precautions and Warnings

Precautions should be taken before taking Advog M 0.3 Tablet, including:

1. Hypoglycemia (Low Blood Sugar): If you also take other blood sugar-lowering drugs, combining Metformin and Voglibose together can raise your risk of hypoglycemia. Recognise the warning signs and symptoms of low blood sugar, which include weakness, disorientation, sweating, and dizziness.
2. Effects on the Digestive System: Voglibose may have adverse effects on the digestive system, including bloating, flatulence, and diarrhoea. These negative effects are typically minor and go away with time. Inform your healthcare practitioner if you have severe or ongoing stomach issues.
3. Metformin is mostly removed via the kidneys, according to renal function. Advog M should be started with kidney function testing in place, and this testing should continue as needed because impaired renal function can influence Metformin clearance. For people with kidney impairment, dosage changes or alternate treatment alternatives may be required.
4. Adherence to Medication: It’s critical to take Advog M as directed by your doctor and to follow the suggested dose regimen. The effectiveness of the drug can be impacted and the risk of problems may rise if doses are missed or exceeded.

Possible Side Effects

Some people may experience negative effects after taking Advog M 0.3 Tablet. The following are typical adverse reactions to metformin with voglibose:

• gastrointestinal distress (flatulence, diarrhoea, and bloating)
• Nausea
• Uncomfortable stomach
• Headache
• Low blood sugar, or hypoglycemia

Typically, these side effects are minor and go away on their own. Notify your healthcare practitioner if you develop any severe or persistent side effects for additional assessment and advice.

Each person will react to Advog M 0.3 Tablet differently. Voglibose may take a few weeks to fully exert its effects, whereas Metformin begins to drop blood sugar levels within a few days of starting the prescription. It’s critical to adhere to your doctor’s recommendations and routinely check your blood sugar levels to determine the medication’s efficacy.For the management of type 2 diabetes, Advog M 0.3 Tablet is frequently suggested as a supplement to diet and exercise. It is not frequently employed as a stand-alone therapy. Your healthcare professional should evaluate the appropriateness of Advog M for your treatment plan based on your particular requirements and medical history.Metformin, one of the ingredients in Advog M, is not linked to weight gain and in some people, may even help with slight weight loss. On the other hand, voglibose does not significantly affect body weight. Individual differences can exist in the overall impact on weight. It’s crucial to keep an eye on your weight and talk to your doctor if you have any concerns.

Your doctor should carefully assess whether Advog M 0.3 Tablet should be used by patients with kidney issues. The kidneys are the main organs responsible for the removal of metformin, and renal dysfunction can influence the drug’s clearance. For people with kidney impairment, dosage changes or alternate treatment alternatives may be required.Advog M does not have any particular food limitations, however it is still necessary to maintain a balanced and healthy diet as part of managing diabetes. A qualified dietician or your healthcare physician can advise you on the best nutritional options to complement your treatment plan.

Conclusion

It is typical to prescribe Advog M 0.3 Tablet, which contains Metformin and Voglibose, for the treatment of type 2 diabetes mellitus. It functions by reducing blood sugar levels in a variety of ways. It is crucial to take the medication as directed, to take safety measures, and to notify your doctor of any side effects or concerns. Diabetes can be effectively managed by making lifestyle changes, such as eating healthily and exercising regularly, in addition to taking medication. For personalised counsel and direction tailored to your unique requirements and circumstances, always seek the opinion of a healthcare expert.